Showing results (2101-2110 of 3,086) with videos related to

Sort By:
Pageof 309
Drug Safety|November 16, 2023
The COVID-19 International Drug Pregnancy Registry (COVID-PR): Protocol ConsiderationsDiego F Wyszynski, Aris T Papageorghiou, Cheryl Renz, et al.
Drug Safety|November 29, 2023
The Unseen Hand: AI-Based Prescribing Decision Support Tools and the Evaluation of Drug Safety and EffectivenessHarriet Dickinson, Dana Y Teltsch, Jan Feifel, et al.
Drug Safety|January 4, 2024
Enhancing Transparency in Defining Studied Drugs: The Open-Source Living DiAna Dictionary for Standardizing Drug Names in the FAERSMichele Fusaroli, Valentina Giunchi, Vera Battini, et al.
Drug Safety|December 13, 2023
Implementation of a Taxonomy-Based Framework for the Selection of Appropriate Drugs and Outcomes for Real-World Data Signal Detection StudiesAstrid Coste, Angel Ys Wong, Charlotte Warren-Gash, et al.
Drug Safety|December 19, 2023
The Critical Intersect of Regulations, Health Technology Assessment, and Drug Safety AssessmentsWen-Wen Yang, Yi-Chen Juan, Grace Hui-Min Wu, et al.
Drug Safety|March 13, 2024
The Reporting Recommendations Intended for Pharmaceutical Risk Minimization Evaluation Studies: Standards for Reporting of Implementation Studies Extension (RIMES-SE)Meredith Y Smith, Elaine H Morrato, Nallely Mora, et al.
Drug Safety|March 5, 2024
Risk Factors Associated with Medication Administration Errors in Children: A Prospective Direct Observational Study of Paediatric InpatientsJohanna I Westbrook, Ling Li, Amanda Woods, et al.
Drug Safety|January 25, 2024
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic ReviewBronya Calvarysky, Idit Dotan, Daniel Shepshelovich, et al.
Drug Safety|December 7, 2023
Optimizing Signal Management in a Vaccine Adverse Event Reporting System: A Proof-of-Concept with COVID-19 Vaccines Using Signs, Symptoms, and Natural Language ProcessingGuojun Dong, Andrew Bate, François Haguinet, et al.
Drug Safety|November 15, 2023
Enhancing Pharmacovigilance in Côte d'Ivoire: Impact of GSK's Training and Mentoring Pilot Project in the Abidjan RegionYolanda Guerra Mendoza, Viviane Jusot, Félix Adou, et al.
Pageof 309